Search research articles
Contact Us
Filters
Showing results (81-90 of 88) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 88 results.
Annals of Neurology
|
December 10, 1999
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française
X P Zhou, M Sanson, K Hoang-Xuan, et al.
International Journal of Cancer
|
March 30, 1999
Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations
X P Zhou, Y J Li, K Hoang-Xuan, et al.
Oncogene
|
November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract
P Mongiat-Artus, C Miquel, M Van der Aa, et al.
Oncogene
|
September 6, 2006
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
C Oliveira, S Velho, C Moutinho, et al.
Chirurgie; Memoires De L'Academie De Chirurgie
|
September 30, 1998
[Contributions of genetics in gastroenterology. Has genetic progress changed the therapeutic management of colorectal neoplasms? "Colon" Group of the Curie Institute]
R J Salmon, B Asselain, L Chauveinc, et al.
British Journal of Cancer
|
November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats
J-F You, O Buhard, M J L Ligtenberg, et al.
Genes, Chromosomes & Cancer
|
March 10, 1998
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites
X P Zhou, J M Hoang, Y J Li, et al.
Journal of Medical Genetics
|
September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
E Domingo, P Laiho, M Ollikainen, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 88) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 88 results.
Annals of Neurology
|
December 10, 1999
Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française
X P Zhou, M Sanson, K Hoang-Xuan, et al.
International Journal of Cancer
|
March 30, 1999
Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations
X P Zhou, Y J Li, K Hoang-Xuan, et al.
Oncogene
|
November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tract
P Mongiat-Artus, C Miquel, M Van der Aa, et al.
Oncogene
|
September 6, 2006
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
C Oliveira, S Velho, C Moutinho, et al.
Chirurgie; Memoires De L'Academie De Chirurgie
|
September 30, 1998
[Contributions of genetics in gastroenterology. Has genetic progress changed the therapeutic management of colorectal neoplasms? "Colon" Group of the Curie Institute]
R J Salmon, B Asselain, L Chauveinc, et al.
British Journal of Cancer
|
November 18, 2010
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats
J-F You, O Buhard, M J L Ligtenberg, et al.
Genes, Chromosomes & Cancer
|
March 10, 1998
Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites
X P Zhou, J M Hoang, Y J Li, et al.
Journal of Medical Genetics
|
September 3, 2004
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
E Domingo, P Laiho, M Ollikainen, et al.
Page
of 9